Phosphodiesterase inhibitors: a potential therapeutic approach for ischemic cerebral injury

Ligia dos Santos Mendes Lemes Soares

Research output: ThesisDoctoral ThesisExternal prepared

Abstract

Cerebral ischemic diseases are among the most prevalent causes of death and the leading cause of adult disability worldwide. Although many studies have investigated the pathophysiological mechanisms involved in the cerebral ischemic injury, no effective pharmacological treatment has been established. Phosphodiesterase inhibitors (PDE-Is) act by different mechanisms including, anti-inflammatory, anti-apoptotic, neurotrophic and neurogenic, which are potential targets for therapy in ischemic conditions. Therefore, this thesis investigated the role of PDE-Is on the cerebral ischemic injury using behavioral and pharmacological approaches. Based on our findings we conclude that PDE-Is could be a useful approach to treating the functional impairments induced by cerebral ischemic diseases.
Original languageEnglish
Awarding Institution
  • Maastricht University
Supervisors/Advisors
  • Steinbusch, Harry, Supervisor
  • Weffort de Oliveira, Rubia Maria, Advisor, External person
  • Prickaerts, Jos, Advisor
Award date1 Dec 2016
Place of PublicationMaastricht
Publication statusPublished - 2016

Keywords

  • cerebral ischemic injury
  • phosphodiesterase inhibitors
  • behavioral approach

Cite this